{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:47:44Z","timestamp":1763765264404},"reference-count":181,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1016\/s0009-8981(01)00717-3","type":"journal-article","created":{"date-parts":[[2002,10,10]],"date-time":"2002-10-10T19:00:31Z","timestamp":1034276431000},"page":"71-97","source":"Crossref","is-referenced-by-count":57,"title":["Screening for prostate cancer with prostate-specific antigen: beware the biases"],"prefix":"10.1016","volume":"315","author":[{"given":"Peter S","family":"Bunting","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0009-8981(01)00717-3_BIB1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0090-4295(99)80181-2","article-title":"Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part II. Early detection strategies","volume":"46","author":"Coley","year":"1995","journal-title":"Urology"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB2","series-title":"The Canadian Guide to Clinical Preventive Health Care (revised 1994)","year":"1991"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB3","unstructured":"www.cua.org, June 1992."},{"issue":"Suppl. 3","key":"10.1016\/S0009-8981(01)00717-3_BIB4","first-page":"1","article-title":"Report prepared for the health technology assessment panel of the NHS executive on the diagnosis, management, treatment and costs of prostate cancer in England and Wales","volume":"79","author":"Chamberlain","year":"1997","journal-title":"Br. J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1464-410x.1999.00905.x","article-title":"Diagnosis and management of early prostate cancer. Report of a British Association of Urological Surgeons Working Party","volume":"83","author":"Dearnaley","year":"1999","journal-title":"BJU Int."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3322\/canjclin.47.5.261","article-title":"American Cancer Society guideline for the early detection of prostate cancer: update 1997","volume":"47","author":"Von Eschenbach","year":"1997","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.7326\/0003-4819-126-6-199703150-00011","article-title":"Screening for prostate cancer. Clinical Guideline: Part III","volume":"126","author":"Coley","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB8","unstructured":"Prostate cancer awareness for men. www.auanet.org."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB9","unstructured":"www.cancernet.nci.nih.gov. Questions and answers about the PSA test."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB10","series-title":"U.S. Preventative Services Task Force Guide to Clinical Preventive Services","year":"1996"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.pu.16.050195.001435","article-title":"PSA screening: a public health dilemma","volume":"16","author":"Mandelson","year":"1995","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB12","first-page":"354","article-title":"Is screening for prostate cancer the current gold standard?\u2014Yes","volume":"33","author":"Lange","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB13","first-page":"348","article-title":"Is screening for prostate cancer the current gold standard?\u2014No","volume":"33","author":"Kramer","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB14","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(94)90071-X","article-title":"Ethics of a prostate cancer screening trial","volume":"343","author":"Adami","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB15","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.274.18.1445","article-title":"Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing","volume":"271","author":"Jacobsen","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF03403900","article-title":"Prostate cancer screening in the midst of controversy: Canadian men's knowledge, beliefs, utilization and future intentions","volume":"88","author":"Mercer","year":"1997","journal-title":"Can. J. Public Health"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB17","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0022-5347(05)67144-3","article-title":"Prostate specific antigen testing and digital rectal examination before and during a randomized trial of screening for prostate cancer: European Randomized Study of Screening for Prostate Cancer, Rotterdam","volume":"164","author":"Beemsterboer","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0959-8049(98)00379-7","article-title":"Rationale for randomised trials of prostate cancer screening","volume":"35","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0090-4295(97)00339-7","article-title":"Cancer of the prostate: a nutritional disease?","volume":"50","author":"Fair","year":"1997","journal-title":"Urology"},{"issue":"4","key":"10.1016\/S0009-8981(01)00717-3_BIB20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1006118628183","article-title":"Diet, androgens, oxidative stress and prostate cancer susceptibility","volume":"17","author":"Fleshner","year":"1998","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB21","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0025-7125(05)70173-5","article-title":"Screening for prostate cancer. The challenge of promoting informed decision making in the absence of definitive evidence of effectiveness","volume":"83","author":"Burack","year":"1999","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB22","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1871::AID-CNCR28>3.0.CO;2-1","article-title":"Family history facilitates the early diagnosis of prostate carcinoma","volume":"80","author":"Walsh","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB23","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0022-5347(01)68194-1","article-title":"Familial prostate cancer: a different disease?","volume":"158","author":"Kupelian","year":"1997","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB24","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0022-5347(01)65588-5","article-title":"Racial differences in a prostate cancer screening study","volume":"156","author":"Smith","year":"1996","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jnci\/89.2.134","article-title":"Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer","volume":"89","author":"Henderson","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJM199608013350502","article-title":"Age-specific reference ranges for serum prostate-specific antigen in black men","volume":"335","author":"Morgan","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB27","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0022-5347(01)64147-8","article-title":"Racial differences in operating characteristics of prostate cancer screening tests","volume":"158","author":"Smith","year":"1997","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB28","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1002\/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO;2-Y","article-title":"Correlation of pathologic findings with progression after radical retropubic prostatectomy","volume":"71","author":"Epstein","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB29","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1001\/jama.269.20.2633","article-title":"An assessment of radical prostatectomy. Time trends, geographic variation and outcomes. The Prostate Patient Outcome Research Team","volume":"269","author":"Lu-Yao","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB30","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0022-5347(17)44889-0","article-title":"Trends in patterns of care for prostate cancer, 1974\u20131983: results of survey by the American College of Surgeons","volume":"136","author":"Schmidt","year":"1986","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2307\/3342875","article-title":"What is the role of early detection and screening in cancer control?","volume":"14","author":"Miller","year":"1993","journal-title":"J. Public Health Policy"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB32","first-page":"122","article-title":"Is screening for prostate cancer necessary in men with symptoms of benign prostatic hyperplasia?","volume":"14","author":"Hall","year":"1996","journal-title":"Sem. Urol. Oncol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB33","unstructured":"Coley et al., 1997 (Ref. [1]), p. 402."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB34","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1001\/jama.276.24.1976","article-title":"Controversies in prostate cancer screening. Analogies to the early lung cancer screening debate","volume":"276","author":"Collins","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB35","series-title":"Principles and practice of screening for diseases","author":"Wilson","year":"1968"},{"issue":"Suppl. 8","key":"10.1016\/S0009-8981(01)00717-3_BIB36","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/1097-0142(19881015)62:1+<1776::AID-CNCR2820621314>3.0.CO;2-V","article-title":"Cancer screening. Degrees of proof and practical application","volume":"62","author":"Hulka","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB37","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/bmj.322.7295.1174","article-title":"Appraising organized screening programs for genetic susceptibility testing","volume":"322","author":"Goel","year":"2001","journal-title":"Br. Med. J."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB38","first-page":"270","article-title":"Prostate-specific antigen testing to screen for prostate cancer","volume":"41","author":"Budenholzer","year":"1995","journal-title":"J. Fam. Pract."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB39","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1525-1500.1999.99033.x","article-title":"Prostate cancer screening: promise and peril\u2014a review","volume":"23","author":"Godley","year":"1999","journal-title":"Cancer Detect. Prev."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB40","first-page":"447","article-title":"Prostate cancer: to screen or not to screen?","volume":"11","author":"Woolf","year":"1997","journal-title":"Oncology"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB41","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1001\/jama.283.22.2975","article-title":"Are increasing 5-y survival rates evidence of success against cancer?","volume":"283","author":"Welch","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0022-5347(17)35487-3","article-title":"The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients","volume":"150","author":"Sakr","year":"1993","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB43","series-title":"Canadian Cancer Statistics","first-page":"47","year":"2000"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB44","unstructured":"W. Sakr, N. Pernick, C. Butler, H. Nassar, V. Pansare, D. Grignon, The prevalence of high grade, clinically occult prostatic adenocarcinoma and its relationship to high grade PIN, Abstract 656, American Urological Association, July 2000."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB45","first-page":"685","article-title":"Prostate cancer: 2. Natural history","volume":"159","author":"Nam","year":"1998","journal-title":"CMAJ"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB46","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0090-4295(99)80339-2","article-title":"Impact of prostate-specific antigen screening on the natural history of prostate cancer","volume":"46","author":"Rosen","year":"1995","journal-title":"Urology"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/(SICI)1097-0045(20000301)42:4<247::AID-PROS1>3.0.CO;2-5","article-title":"Analysis of recent trends in prostate cancer incidence and mortality","volume":"42","author":"Dennis","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB48","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7326\/0003-4819-126-5-199703010-00010","article-title":"Early detection of prostate cancer: Part I. Prior probability and effectiveness of tests","volume":"126","author":"Coley","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1098-2388(200001\/02)18:1<29::AID-SSU5>3.0.CO;2-Y","article-title":"Screening for prostate cancer","volume":"18","author":"Brawer","year":"2000","journal-title":"Sem. Surg. Oncol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB50","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0022-5347(17)35233-3","article-title":"Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men","volume":"151","author":"Catalona","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB51","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0022-5347(17)40211-4","article-title":"Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen","volume":"143","author":"Cooner","year":"1990","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB52","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF01671155","article-title":"Progress and problems in screening for carcinoma of the prostate [Review]","volume":"13","author":"Chodak","year":"1989","journal-title":"World J. Surg."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB53","series-title":"Prostate Cancer","article-title":"Experience with the German annual preventive checkup examination","author":"Faul","year":"1982"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.215.1.81","article-title":"Cancer of the prostate gland. Results of early diagnosis and therapy undertaken for cure of the disease","volume":"215","author":"Gilbertsen","year":"1971","journal-title":"JAMA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB55","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1001\/jama.1960.03030140005002","article-title":"Evaluation of annual examination in the detection of cancer: special reference to cancer of the gastrointestinal tract, prostate, breast, and female reproductive tract","volume":"174","author":"Jenson","year":"1960","journal-title":"JAMA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB56","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1148\/radiology.168.2.3293108","article-title":"Prostate cancer: comparison of transrectal US and digital rectal examination for screening","volume":"168","author":"Lee","year":"1988","journal-title":"Radiology"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB57","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0022-5347(17)36733-2","article-title":"A screening study of prostate cancer in high risk families","volume":"148","author":"McWhorter","year":"1992","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB58","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/1097-0142(19940901)74:5<1615::AID-CNCR2820740520>3.0.CO;2-6","article-title":"Relative sensitivity and specificity of serum prostate specific antigen (PSA) concentration compared with age referenced PSA, PSA density and PSA change","volume":"74","author":"Mettlin","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB59","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0022-5347(17)42069-6","article-title":"An evaluation of serial digital rectal examinations in screening for prostate cancer","volume":"140","author":"Mueller","year":"1988","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB60","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0022-5347(17)44055-9","article-title":"Impact of routine screening for adenocarcinoma of the prostate on stage distribution","volume":"137","author":"Thompson","year":"1987","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB61","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/1097-0142(19850701)56:1<173::AID-CNCR2820560127>3.0.CO;2-0","article-title":"Screening for carcinoma of the prostate. Rectal examination, and enzymatic and radioimmunologic measurement of serum acid phosphatase compared","volume":"56","author":"Vihko","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000473390","article-title":"Digital rectal examination to screen for prostatic cancer","volume":"15","author":"Waaler","year":"1988","journal-title":"Eur. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB63","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0022-5347(17)32457-6","article-title":"Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer","volume":"152","author":"Flanigan","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB64","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0009-9120(99)00068-5","article-title":"Is there still a role for prostatic acid phosphatase? CSCC position statement","volume":"32","author":"Bunting","year":"1999","journal-title":"Clin. Biochem."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB65","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0022-5347(17)38491-4","article-title":"Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate","volume":"145","author":"Oesterling","year":"1991","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB66","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0022-5347(05)68543-6","article-title":"Prostate specific antigen: a decade of discovery\u2014what we have learned and where we are going","volume":"162","author":"Polascik","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB67","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0022-5347(01)63571-7","article-title":"The use of percent free prostate specific antigen for staging clinically localized prostate cancer","volume":"159","author":"Pannek","year":"1998","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB68","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/archinte.153.22.2529","article-title":"An evaluation of prostate-specific antigen as a screening test for prostate cancer","volume":"153","author":"Dorr","year":"1993","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB69","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","article-title":"Measurement of prostate specific antigen in serum as a screening test for prostate cancer","volume":"324","author":"Catalona","year":"1981","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/S0009-8981(01)00717-3_BIB70","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000474899","article-title":"Comparison between digital rectal examination, prostate specific antigen and transrectal ultrasound in symptomatic patients","volume":"21","author":"Puppo","year":"1992","journal-title":"Eur. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB71","first-page":"313A","article-title":"Detection of prostate cancer by digital rectal exam, prostate specific antigen, and transrectal ultrasonography","volume":"143","author":"Marcus","year":"1990","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB72","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/ajcp\/92.6.760","article-title":"Serum prostate specific antigen and prostate pathology in men having simple prostatectomy","volume":"92","author":"Brawer","year":"1989","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB73","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/cncr.2820690521","article-title":"The relationship of prostate specific antigen to digital rectal examination and transrectal ultrasonography","volume":"69","author":"Babaian","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB74","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0090-4295(91)80283-D","article-title":"Early detection program for prostate cancer: results and identification of high-risk population","volume":"37","author":"Babaian","year":"1991","journal-title":"Urology"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB75","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0022-5347(17)42624-3","article-title":"Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer","volume":"139","author":"Cooner","year":"1988","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB76","first-page":"371","article-title":"Screening for carcinoma of the prostate with prostate specific antigen","volume":"21","author":"Muschenheim","year":"1991","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB77","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0022-5347(17)37401-3","article-title":"Screening for prostatic carcinoma with prostate specific antigen","volume":"147","author":"Brawer","year":"1992","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB78","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S0022-5347(17)38076-X","article-title":"Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination","volume":"146","author":"Vallancien","year":"1991","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB79","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0094-0143(05)70333-5","article-title":"The use of prostate-specific antigen and free\/total prostate specific antigen in the diagnosis of localized prostate cancer","volume":"23","author":"Partin","year":"1996","journal-title":"Urol. Clin. NA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB80","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0022-5347(17)40211-4","article-title":"Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen","volume":"143","author":"Cooner","year":"1990","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB81","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-5347(17)34880-2","article-title":"Systematic sextant biopsies in 651 patients referred for prostate evaluation","volume":"151","author":"Hammerer","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB82","first-page":"1500","article-title":"Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography","volume":"52","author":"Ellis","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB83","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.270.8.948","article-title":"Detection of organ-confined prostate cancer is increased through prostate specific antigen based screening","volume":"270","author":"Catalona","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB84","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0090-4295(95)80001-8","article-title":"Second Standard Conference on international standardization of prostate-specific antigen immunoassays: September 1 and 2, 1994","volume":"45","author":"Stamey","year":"1995","journal-title":"Urology"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB85_1","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/clinchem\/46.9.1310","article-title":"Reference reagents for prostate-specific antigen (PSA): establishment of the First International Standards for free PSA and PSA (90:10)","volume":"46","author":"Rafferty","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB85_2","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/clinchem\/46.9.1291","article-title":"WHO First International Standards for prostate-specific antigen: the beginning of the end for assay discrepancies?","volume":"46","author":"Chan","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB86","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/jama.273.4.289","article-title":"A prospective evaluation of plasma prostate-specific antigen for detection of prostate cancer","volume":"273","author":"Gann","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB87","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0090-4295(99)00271-X","article-title":"Prostate-specific antigen testing for early diagnosis of prostate cancer: formulation of guidelines","volume":"54","author":"Carter","year":"1999","journal-title":"Urology"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB88","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0022-5347(05)68543-6","article-title":"Prostate specific antigen: a decade of discovery\u2014what we have learned and where we are going","volume":"162","author":"Polascik","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB89","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000019615","article-title":"Etiology and diagnosis of prostate cancer: what's new?","volume":"33","author":"Zlotta","year":"1998","journal-title":"Eur. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB90","first-page":"140","article-title":"Advances in the application of prostate-specific antigen in the detection of early-stage prostate cancer","volume":"26","author":"Kamoi","year":"1999","journal-title":"Sem. Oncol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB91","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1043-2760(99)00225-8","volume":"11","author":"Diamandis","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB92","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0090-4295(99)00585-3","article-title":"Clinical value of human glandular kallikrein and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen concentrations 3.0 ng\/mL or greater","volume":"55","author":"Becker","year":"2000","journal-title":"Urology"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB93","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jama.270.7.860","article-title":"Serum prostate-specific antigen in a community-based population of healthy men","volume":"270","author":"Oesterling","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB94","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.267.16.2215","article-title":"Longitudinal evaluation of prostate-specific antigen concentrations in men with and without prostate diseases","volume":"267","author":"Carter","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB95","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0009-9120(95)91342-Z","article-title":"A guide to the interpretation of serum prostate specific antigen concentrations","volume":"28","author":"Bunting","year":"1995","journal-title":"Clin. Biochem."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB96","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0090-4295(98)00617-7","article-title":"Free\/total PSA ratio improves differentiation of benign and malignant disease of the prostate: critical analysis of two different test populations","volume":"53","author":"Veltri","year":"1999","journal-title":"Urology"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB97","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1464-410X.1997.00130.x","article-title":"Free and total prostate-specific antigen in a screened population","volume":"79","author":"Bangma","year":"1997","journal-title":"Br. J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB98","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-5347(01)63996-X","article-title":"Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer","volume":"159","author":"Woodrum","year":"1998","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB99","first-page":"27","article-title":"Complexed PSA: the wave of the future","volume":"1","author":"Brawer","year":"1999","journal-title":"Rev. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/clinchem\/46.1.55","article-title":"Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?","volume":"46","author":"Jung","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB101","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0022-5347(05)67646-X","article-title":"Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer","volume":"163","author":"Brawer","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB102","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1464-410x.1999.00311.x","article-title":"The stability of free and bound prostate-specific antigen","volume":"84","author":"Cartledge","year":"1999","journal-title":"BJU Int."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB103","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0090-4295(99)00547-6","article-title":"Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial","volume":"55","author":"Catalona","year":"2000","journal-title":"Urology"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB104","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0090-4295(00)00672-5","article-title":"Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network","volume":"56","author":"Finne","year":"2000","journal-title":"Urology"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00005392-199904010-00841","article-title":"Rational PSA screening strategies for prostate cancer: computer simulations of age ranges, PSA cutoffs, and testing intervals (abstract)","volume":"161","author":"Ross","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB106","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/jama.277.18.1456","article-title":"Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer","volume":"277","author":"Carter","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB107","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/jama.276.16.1309","article-title":"Longitudinal screening for prostate cancer with prostate-specific antigen","volume":"276","author":"Smith","year":"1996","journal-title":"JAMA"},{"issue":"5 Pt 1","key":"10.1016\/S0009-8981(01)00717-3_BIB108","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/S0022-5347(17)32460-6","article-title":"Diagnosis of prostatic carcinoma: the yield of serum prostate-specific antigen, digital rectal examination and transrectal ultrasound","volume":"152","author":"Ellis","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB109","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0022-5347(17)35304-1","article-title":"Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values","volume":"151","author":"Keetch","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB110","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0022-5347(01)63951-X","article-title":"Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer","volume":"159","author":"Levine","year":"1998","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB111","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-5347(05)67367-3","article-title":"A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection","volume":"164","author":"Naughton","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB112","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000474176","article-title":"Clinical prognostic criteria for later diagnosis of prostate carcinoma in patients with isolated prostatic intraepithelial neoplasia","volume":"30","author":"Zlotta","year":"1996","journal-title":"Eur. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB113","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3322\/canjclin.45.3.134","article-title":"Screening for prostate cancer: an analysis of the early experience","volume":"45","author":"Slavin","year":"1995","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB114","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.271.5.368","article-title":"Pathologic and clinical findings to predict tumor extent of nonpalpable (Stage T1c) prostate cancer","volume":"271","author":"Epstein","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB115","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF01300181","article-title":"Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer","volume":"15","author":"Hoedemaeker","year":"1997","journal-title":"World J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB116","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0022-5347(05)67373-9","article-title":"Histopathological prostate cancer characteristics at radical prostatectomy after population based screening","volume":"164","author":"Hoedemaeker","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB117","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<150::AID-CNCR25>3.0.CO;2-3","article-title":"The results of a five-y early prostate cancer detection intervention","volume":"77","author":"Mettlin","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB118","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1023\/A:1008446208963","article-title":"PSA screening\u2014current controversy","volume":"9","author":"Svetec","year":"1998","journal-title":"Ann. Oncol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB119","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0022-5347(05)67645-8","article-title":"Positive and negative biopsies in the pre-prostate specific antigen and prostate specific antigen eras, 1980 to 1997","volume":"163","author":"Roberts","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB120","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0959-8049(05)80339-9","article-title":"Screening for prostate cancer\u2014necessity or nonsense?","volume":"29A","author":"Schroder","year":"1993","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB121","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0090-4295(94)80264-5","article-title":"Heterogeneity of prostate cancer in radical prostatectomy specimens","volume":"43","author":"Alhara","year":"1994","journal-title":"Urology"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB122","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0090-4295(98)00003-X","article-title":"Positive biopsy rate consistently increases with age at the same prostate-specific antigen concentration in patients with normal digital rectal examination","volume":"51","author":"Orozco","year":"1998","journal-title":"Urology"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB123","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0090-4295(98)00466-X","article-title":"The influence of age and prostate specific antigen on the chance of curable prostate cancer among men with non-palpable disease","volume":"53","author":"Carter","year":"1999","journal-title":"Urology"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB124","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ssu.2980100110","article-title":"Staging of prostate cancer","volume":"10","author":"Bostwick","year":"1994","journal-title":"Sem. Surg. Oncol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB125","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/S0022-5347(01)66790-9","article-title":"Tumor volume and prostate specific antigen: implications for early detection and defining a window of curability","volume":"154","author":"Babaian","year":"1995","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB126","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0022-5347(05)67713-0","article-title":"Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens","volume":"163","author":"Stamey","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB127","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.277.18.1445","article-title":"Combination of prostate-specific antigen, clinical stage, and Gleason Score to predict pathological stage of localized prostate cancer","volume":"277","author":"Partin","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB128","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/clinchem\/45.7.987","article-title":"Estimation of prostate cancer probability by logistic regression: free and total prostate specific antigen, digital rectal examination and heredity are significant variables","volume":"45","author":"Virtanen","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB129","first-page":"60","article-title":"Use of artificial neural networks in the clinical staging of prostate cancer: implications for prostate brachytherapy","volume":"6","author":"Garruto","year":"2000","journal-title":"Tech. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB130","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1464-410X.1996.13210.x","article-title":"Molecular and cellular biology of the prostate: is it clinically relevant?","volume":"78","author":"Habib","year":"1996","journal-title":"Br. J. Urol."},{"issue":"Suppl. 1","key":"10.1016\/S0009-8981(01)00717-3_BIB131","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1464-410X.1997.tb00798.x","article-title":"Tumor-suppressor genes in prostatic oncogenesis: a positional approach","volume":"79","author":"Bookstein","year":"1997","journal-title":"Br. J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB132","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/labinvest.3780096","article-title":"Identification of genetic markers for prostatic cancer progression","volume":"80","author":"Alers","year":"2000","journal-title":"Lab. Invest."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB133","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.279.5350.563","article-title":"Plasma insulin-like growth factor and prostate cancer risk: a prospective study","volume":"279","author":"Chan","year":"1998","journal-title":"Science"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB134","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0022-5347(01)63776-5","article-title":"Low p27 expression predicts poor disease-free survival in patients with prostate cancer","volume":"159","author":"Yang","year":"1998","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB135","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/302960","article-title":"Genome wide scan for prostate cancer aggressiveness loci","volume":"67","author":"Witte","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB136","first-page":"4013","article-title":"Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX","volume":"5","author":"Lange","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB137","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1086\/302807","article-title":"Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics","volume":"66","author":"Xu","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB138","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1098-2388(200001\/02)18:1<10::AID-SSU3>3.0.CO;2-V","article-title":"Prostate-specific membrane antigen (PSMA): current benefits and future value","volume":"18","author":"Elgamal","year":"2000","journal-title":"Sem. Surg. Oncol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB139","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1098-2388(200001\/02)18:1<17::AID-SSU4>3.0.CO;2-7","article-title":"Detection of extraprostatic prostate cells utilizing reverse transcription-polymerase chain reaction","volume":"18","author":"Su","year":"2000","journal-title":"Sem. Surg. Oncol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB140","doi-asserted-by":"crossref","first-page":"995","DOI":"10.5858\/2000-124-0995-PFIPC","article-title":"Prognostic factors in prostate cancer. College of American Pathologists consensus statement 1999","volume":"124","author":"Bostwick","year":"2000","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB141","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1001\/jama.283.24.3217","article-title":"Comparison of recommendations of urologists and radiation oncologists for treatment of clinically localized prostate cancer","volume":"283","author":"Fowler","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB142","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(96)09380-4","article-title":"Population based study of long term survival in patients with clinically localised prostate cancer","volume":"349","author":"Lu-Yao","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB143","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archfami.2.5.487","article-title":"A structured literature review of treatment for localized prostate cancer","volume":"2","author":"Wasson","year":"1993","journal-title":"Arch. Fam. Med."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB144","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1023\/A:1008446208963","article-title":"PSA screening\u2014current controversy","volume":"9","author":"Svetec","year":"1998","journal-title":"Ann. Oncol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB145","first-page":"1265","article-title":"Prostate cancer: 6. Surgical treatment of localized disease","volume":"159","author":"Goldenberg","year":"1998","journal-title":"CMAJ"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB146","first-page":"1381","article-title":"Prostate cancer: 7. Radiation therapy for localized disease","volume":"159","author":"Warde","year":"1998","journal-title":"CMAJ"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB147","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jama.272.10.773","article-title":"Screening for prostate cancer. A decision analytic view","volume":"272","author":"Krahn","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB148","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1001\/jama.269.20.2650","article-title":"A decision analysis of alternative treatment strategies for clinically localized prostate cancer","volume":"269","author":"Fleming","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB149","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1454::AID-CNCR25>3.0.CO;2-S","article-title":"Quality-of-life outcomes for men with prostate carcinoma detected by screening","volume":"88","author":"Smith","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB150","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1055-3207(18)30183-2","article-title":"Prostate cancer: a challenge for screening","volume":"8","author":"Donnell","year":"1999","journal-title":"Surg. Oncol. Clin. NA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB151","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0022-5347(01)61630-6","article-title":"The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study","volume":"161","author":"Rietbergen","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB152","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1445::AID-CNCR24>3.0.CO;2-T","article-title":"Prostate carcinoma trends in three counties in Sweden 1987\u20131996. Results from a population-based national cancer register","volume":"88","author":"Sandblom","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB153","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/S0959-8049(00)00113-1","article-title":"Prostate cancer screening in the Tyol, Austria: experience and results","volume":"36","author":"Horninger","year":"2000","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB154","first-page":"88","article-title":"Decrease in prostate cancer mortality following introduction of prostate specific antigen (PSA) screening in the federal state of Tyol, Austria","volume":"163","author":"Bartsch","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB155","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0022-5347(01)61628-8","article-title":"Downward trend in prostate cancer mortality in Quebec and Canada","volume":"161","author":"Meyer","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB156","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1023\/A:1008805718310","article-title":"The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the U.S.","volume":"9","author":"Legler","year":"1998","journal-title":"Cancer, Causes Control"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB157","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0009-9120(98)00052-6","article-title":"Prostate-specific antigen utilization in Ontario: extent of testing in patients with and without cancer","volume":"31","author":"Bunting","year":"1998","journal-title":"Clin. Biochem."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB158","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/jnci\/91.12.1017","article-title":"Cancer surveillance series: interpreting trends in prostate cancer: Part I. Evidence of the effects of screening in recent prostate cancer incidence, mortality and survival rates","volume":"91","author":"Hankey","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB159","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/jnci\/91.12.1033","article-title":"Cancer surveillance series: interpreting trends in prostate cancer: Part III. Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality","volume":"91","author":"Etzioni","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0090-4295(96)00603-6","article-title":"Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer","volume":"48","author":"Pearson","year":"1996","journal-title":"Urology"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB161","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1023\/A:1008428327309","article-title":"PSA screening for prostate cancer: the current controversy","volume":"9","author":"de Koning","year":"1998","journal-title":"Ann. Oncol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB162","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0094-0143(21)01367-7","article-title":"Economics of screening for carcinoma of the prostate","volume":"17","author":"Optenberg","year":"1990","journal-title":"Urol. Clin. NA"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB163","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/1097-0142(19941001)74:7+<2016::AID-CNCR2820741705>3.0.CO;2-J","article-title":"Prostate cancer screening. Appropriate choices?","volume":"74","author":"Littrup","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB164","doi-asserted-by":"crossref","first-page":"468","DOI":"10.7326\/0003-4819-126-6-199703150-00010","article-title":"Early detection of prostate cancer. Part II: Estimating the risks, benefits and costs","volume":"126","author":"Coley","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB165","first-page":"977","article-title":"The economic burden of prostate cancer: forecasts from the Montreal Prostate Model","volume":"162","author":"Grover","year":"2000","journal-title":"CMAJ"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB166","first-page":"1533","article-title":"The economics of prostate cancer screening","volume":"11","author":"Benoit","year":"1997","journal-title":"Oncology"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB167","first-page":"49","article-title":"Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen","volume":"160","author":"Krahn","year":"1999","journal-title":"CMAJ"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB168","first-page":"685","article-title":"Prostate cancer: 12. The economic burden","volume":"160","author":"Grover","year":"1999","journal-title":"CMAJ"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB169","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0749-3797(18)30325-8","article-title":"Attitudes and practices of primary care physicians for prostate cancer screening","volume":"12","author":"Hoffman","year":"1996","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB170","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000475051","article-title":"Attitudes of European urologists to early prostatic carcinoma II. Attitude to therapy and to screening examinations","volume":"28","author":"Hansen","year":"1995","journal-title":"Eur. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB171","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/bmj.319.7212.731","article-title":"Decision aids for patients facing health treatment or screening decisions: systematic review","volume":"319","author":"O'Connor","year":"1999","journal-title":"Br. Med. J."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB172","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0272989X0002000102","article-title":"What questions do patients with curable prostate cancer want answered?","volume":"20","author":"Feldman-Stewart","year":"2000","journal-title":"Med. Decis. Making"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB173","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archinte.156.12.1333","article-title":"The impact of informed consent on patient interest in prostate-specific antigen screening","volume":"156","author":"Wolf","year":"1996","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB174","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archfami.8.4.333","article-title":"A randomized controlled trial of shared decision making for prostate cancer screening","volume":"8","author":"Volk","year":"1999","journal-title":"Arch. Fam. Med."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB175","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0022-5347(17)32362-5","article-title":"The use of prostate specific antigen for prostate cancer screening: a managed care perspective","volume":"152","author":"Handley","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB176","unstructured":"www.moh.gov.on.ca."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB177","unstructured":"www.healthdialogue.com."},{"key":"10.1016\/S0009-8981(01)00717-3_BIB178","first-page":"789","article-title":"PSA screening: a view from the front lines","volume":"162","author":"Greiver","year":"2000","journal-title":"CMAJ"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB179","first-page":"791","article-title":"PSA screening: the bottom line","volume":"162","author":"Elhilali","year":"2000","journal-title":"CMAJ"},{"key":"10.1016\/S0009-8981(01)00717-3_BIB180","first-page":"315","article-title":"Prostate cancer screening. Why the controversy?","volume":"4","author":"Walther","year":"1995","journal-title":"Adv. Urol. Oncol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898101007173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898101007173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T14:28:32Z","timestamp":1680964112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898101007173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":181,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S0009898101007173"],"URL":"https:\/\/doi.org\/10.1016\/s0009-8981(01)00717-3","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}